Fri, August 6, 2021

Gena Wang Maintained (VIR) at Buy with Decreased Target to $71 on, Aug 6th, 2021

Gena Wang of Barclays, Maintained "Vir Biotechnology, Inc." (VIR) at Buy with Decreased Target from $96 to $71 on, Aug 6th, 2021.

Gena, nor any peers, have made any analyst calls on VIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30